• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY Back to Search Results
Model Number 1506-10-002
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Codes Adhesion(s) (1695); Pain (1994); No Code Available (3191)
Date of Event 03/12/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
On (b)(6) 2015, the patient underwent total left knee arthroplasty due to osteoarthritis.The patella was resurfaced.The surgeon reported no intraoperative complications.The patient was implanted with the attune knee system and unknown bone cement.On (b)(6) 2018, the patient underwent a left knee revision due to loosening of the tibial component, patellar instability, and pain.The surgeon reported the tibial component was completely de-bonded from the cement mantle and was extracted with absolutely no work.He noted the femoral component was well-fixed but easily extracted with no significant bone loss.The surgeon indicated the patella was found to be well-fixed, tracked well and no overt explanation for the patients¿ subjective sense of patellar instability.He noted a band of fibrous tissue that overhung the patellar component which was debrided.Was retained.The patient was implanted with a competitor system and there were no complications to the procedure.Doi: (b)(6) 2015 dor: (b)(6) 2018 (lt knee).Primary product information can be found on page 9/19 and 10/19 of the attached medical records.Please add 2 unknown cement products were used during primary operation, as noted in the operative report on page 6/17 of the attached medical records.Please add hospital account information.Awareness date is (b)(6) 2019.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary
=
> no device associated with this report was received for examination.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE RP TIB BASE SZ 2 CEM
Common Device Name
ATTUNE IMPLANT : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
MDR Report Key9484166
Report Number1818910-2019-123661
Device Sequence Number11794772
Product Code NJL
UDI-Device Identifier10603295042563
UDI-Public10603295042563
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2018
Reporter Type Manufacturer
Report Source other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2024
Device Model Number1506-10-002
Device Catalogue Number150610002
Device Lot Number7965695
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 11/25/2019
Supplement Date Received by Manufacturer01/20/2020
Initial Report FDA Received Date12/17/2019
Supplement Report FDA Received Date01/21/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age47 YR
-
-